NCT07392099 Comparison of the Efficacy of an Empowered Relief Single-Session Versus Standard Care for Reducing Postoperative Pain Following Elective Orthopedic Surgery: A Randomized Controlled Trial
| NCT ID | NCT07392099 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université de Sherbrooke |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 134 participants |
| Start Date | 2025-05-05 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 134 participants in total. It began in 2025-05-05 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the efficacy and acceptability of the French-Canadian version of ER compared to standard care in reducing postoperative pain and improving recovery outcomes at 6-week and 3-month follow-ups after elective orthopedic surgery.
Eligibility Criteria
Inclusion Criteria: * Pain \>4/10 for \>3 months related to the surgical indication * French fluency * Ability to adhere to and complete study protocol * Males and females, 18+ Exclusion Criteria: * Participated in another project that may cause bias in the study results * Pain related to cancer * Cognitive impairment, non-French speaking, or factors that would preclude comprehension of material or full participation in ER * Previous participation in ER
Frequently Asked Questions
Who can join the NCT07392099 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07392099 currently recruiting?
Yes, NCT07392099 is actively recruiting participants. Visit ClinicalTrials.gov or contact Université de Sherbrooke to inquire about joining.
Where is the NCT07392099 trial being conducted?
This trial is being conducted at Sherbrooke, Canada.
Who is sponsoring the NCT07392099 clinical trial?
NCT07392099 is sponsored by Université de Sherbrooke. The trial plans to enroll 134 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.